Literature DB >> 21520076

Enhanced lipid-but not carbohydrate-supported mitochondrial respiration in skeletal muscle of PGC-1α overexpressing mice.

Joris Hoeks1, Zolt Arany, Esther Phielix, Esther Moonen-Kornips, Matthijs K C Hesselink, Patrick Schrauwen.   

Abstract

Skeletal muscle mitochondrial dysfunction has been linked to several disease states as well as the process of aging. A possible factor involved is the peroxisome proliferator-activated receptor (PPAR) γ co-activator 1α (PGC-1α), a major player in the regulation of skeletal muscle mitochondrial metabolism. However, it is currently unknown whether PGC-1α, besides stimulating mitochondrial proliferation, also affects the functional capacity per mitochondrion. Therefore, we here tested whether PGC-1α overexpression, besides increasing mitochondrial content, also leads to intrinsic mitochondrial adaptations. Skeletal muscle mitochondria from 10 male, muscle-specific PGC-1α overexpressing mice (PGC-1αTg) and 8 wild-type (WT) mice were isolated. Equal mitochondrial quantities were then analyzed for their oxidative capacity by high-resolution respirometry, fuelled by a carbohydrate-derived (pyruvate) and a lipid (palmitoyl-CoA plus carnitine) substrate. Additionally, mitochondria were tested for reactive oxygen species (superoxide) production and fatty acid (FA)-induced uncoupling. PGC-1αTg mitochondria were characterized by an improved intrinsic mitochondrial fat oxidative capacity as evidenced by pronounced increase in ADP-stimulated respiration (P < 0.001) and maximal uncoupled respiration (P < 0.001) upon palmitoyl-CoA plus carnitine. Interestingly, intrinsic mitochondrial capacity on a carbohydrate-derived substrate tended to be reduced. Furthermore, the sensitivity to FA-induced uncoupling was diminished in PGC-1αTg mitochondria (P = 0.02) and this was accompanied by a blunted reduction in mitochondrial ROS production upon FAs in PGC-1αTg versus WT mitochondria (P = 0.04). Uncoupling protein 3 (UCP3) levels were markedly reduced in PGC-1αTg mitochondria (P < 0.001). Taken together, in addition to stimulating mitochondrial proliferation in skeletal muscle, we show here that overexpression of PGC-1α leads to intrinsic mitochondrial adaptations that seem restricted to fat metabolism.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21520076     DOI: 10.1002/jcp.22812

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  16 in total

Review 1.  The role of PGC-1 coactivators in aging skeletal muscle and heart.

Authors:  Lloye M Dillon; Adriana P Rebelo; Carlos T Moraes
Journal:  IUBMB Life       Date:  2012-01-25       Impact factor: 3.885

2.  Targeting of mitochondrial reactive oxygen species production does not avert lipid-induced insulin resistance in muscle tissue from mice.

Authors:  S Paglialunga; B van Bree; M Bosma; M P Valdecantos; E Amengual-Cladera; J A Jörgensen; D van Beurden; G J M den Hartog; D M Ouwens; J J Briedé; P Schrauwen; J Hoeks
Journal:  Diabetologia       Date:  2012-07-12       Impact factor: 10.122

3.  Increasing the level of peroxisome proliferator-activated receptor γ coactivator-1α in podocytes results in collapsing glomerulopathy.

Authors:  Szu-Yuan Li; Jihwan Park; Chengxiang Qiu; Seung Hyeok Han; Matthew B Palmer; Zoltan Arany; Katalin Susztak
Journal:  JCI Insight       Date:  2017-07-20

Review 4.  The many roles of PGC-1α in muscle--recent developments.

Authors:  Mun Chun Chan; Zolt Arany
Journal:  Metabolism       Date:  2014-01-17       Impact factor: 8.694

Review 5.  Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus.

Authors:  Matthijs K C Hesselink; Vera Schrauwen-Hinderling; Patrick Schrauwen
Journal:  Nat Rev Endocrinol       Date:  2016-07-22       Impact factor: 43.330

6.  Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.

Authors:  Silvie Timmers; Ellen Konings; Lena Bilet; Riekelt H Houtkooper; Tineke van de Weijer; Gijs H Goossens; Joris Hoeks; Sophie van der Krieken; Dongryeol Ryu; Sander Kersten; Esther Moonen-Kornips; Matthijs K C Hesselink; Iris Kunz; Vera B Schrauwen-Hinderling; Ellen Blaak; Johan Auwerx; Patrick Schrauwen
Journal:  Cell Metab       Date:  2011-11-02       Impact factor: 27.287

7.  Mouse studies to shape clinical trials for mitochondrial diseases: high fat diet in Harlequin mice.

Authors:  Manuel Schiff; Paule Bénit; Riyad El-Khoury; Dimitri Schlemmer; Jean-François Benoist; Pierre Rustin
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

8.  PGC-1α affects aging-related changes in muscle and motor function by modulating specific exercise-mediated changes in old mice.

Authors:  Jonathan F Gill; Gesa Santos; Svenia Schnyder; Christoph Handschin
Journal:  Aging Cell       Date:  2017-10-25       Impact factor: 9.304

Review 9.  The Implication of PGC-1α on Fatty Acid Transport across Plasma and Mitochondrial Membranes in the Insulin Sensitive Tissues.

Authors:  Elżbieta Supruniuk; Agnieszka Mikłosz; Adrian Chabowski
Journal:  Front Physiol       Date:  2017-11-15       Impact factor: 4.566

10.  Relationship of C5L2 receptor to skeletal muscle substrate utilization.

Authors:  Christian Roy; Sabina Paglialunga; Gert Schaart; Esther Moonen-Kornips; Ruth C Meex; Esther Phielix; Joris Hoeks; Matthijs K C Hesselink; Katherine Cianflone; Patrick Schrauwen
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.